INTERNATIONAL PATENT: WESTVAC BIOPHARMA TECH (BEIJING) CO., LTD., 北京威斯克生物医药科技有限公司 FILES APPLICATION FOR "USE OF NITROIMIDAZOLE DERIVATIVE OR PHARMACEUTICAL COMBINATION IN PREPARATION OF MEDICAMENT AGAINST DRUG-SENSITIVE TUBERCULOSIS"

Posted On: 2026-04-04

GENEVA, April 4 -- WESTVAC BIOPHARMA TECH (BEIJING) CO., LTD. (Floors1-4, Building 7, No.21 Tianhe West Road, Zhongguancun Science Park, Daxing Biomedical Industry Base, Daxing District,Beijing 102629), 北京威斯克生物医药科技有限公司 (中国北京市大兴区中关村科技园区大兴生物医药产业基地天河西路21号院7号楼一至四层) filed a patent application (PCT/CN2024/122270) for "USE OF NITROIMIDAZOLE DERIVATIVE OR PHARMACEUTICAL COMBINATION IN PREPAR...

Click here to read full article from source

इस लेख के रीप्रिंट को खरीदने या इस प्रकाशन का पूरा फ़ीड प्राप्त करने के लिए, कृपया हमे संपर्क करें.

विशेष

Category

Source

Publication

Location

INTERNATIONAL PATENT: WESTVAC BIOPHARMA TECH (BEIJING) CO., LTD., 北京威斯克生物医药科技有限公司 FILES APPLICATION FOR "USE OF NITROIMIDAZOLE DERIVATIVE OR PHARMACEUTICAL COMBINATION IN PREPARATION OF MEDICAMENT AGAINST DRUG-SENSITIVE TUBERCULOSIS"